These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
133 related items for PubMed ID: 21663397
21. Gut-liver axis improves with meloxicam treatment after cirrhotic liver resection. Hamza AR, Krasniqi AS, Srinivasan PK, Afify M, Bleilevens C, Klinge U, Tolba RH. World J Gastroenterol; 2014 Oct 28; 20(40):14841-54. PubMed ID: 25356044 [Abstract] [Full Text] [Related]
22. Evaluation of pharmacological profile of meloxicam as an anti-inflammatory agent, with particular reference to its relative selectivity for cyclooxygenase-2 over cyclooxygenase-1. Ogino K, Hatanaka K, Kawamura M, Katori M, Harada Y. Pharmacology; 1997 Jul 28; 55(1):44-53. PubMed ID: 9309800 [Abstract] [Full Text] [Related]
29. Inhibition of cyclooxygenase-2 (COX-2) by meloxicam decreases the incidence of ovarian hyperstimulation syndrome in a rat model. Quintana R, Kopcow L, Marconi G, Young E, Yovanovich C, Paz DA. Fertil Steril; 2008 Oct 28; 90(4 Suppl):1511-6. PubMed ID: 18166186 [Abstract] [Full Text] [Related]
31. COX 2 selectivity of non-steroidal anti-inflammatory drugs and perioperative blood loss in hip surgery. A randomized comparison of indomethacin and meloxicam. Weber EW, Slappendel R, Durieux ME, Dirksen R, van der Heide H, Spruit M. Eur J Anaesthesiol; 2003 Dec 28; 20(12):963-6. PubMed ID: 14690098 [Abstract] [Full Text] [Related]
32. Aspirin, but not the more selective cyclooxygenase (COX)-2 inhibitors meloxicam and SC 58125, aggravates postischaemic cardiac dysfunction, independent of COX function. Heindl B, Becker BF. Naunyn Schmiedebergs Arch Pharmacol; 2001 Feb 28; 363(2):233-40. PubMed ID: 11218076 [Abstract] [Full Text] [Related]
34. The effectiveness of two COX-2 inhibitors in the prophylaxis against heterotopic new bone formation: an experimental study in rabbits. Tsailas PG, Babis GC, Nikolopoulos K, Soucacos PN, Korres DS. J Surg Res; 2009 Jan 28; 151(1):108-14. PubMed ID: 18656899 [Abstract] [Full Text] [Related]
35. Effect of oral administration of a continuous 18 day regimen of meloxicam on ovulation: experience of a randomized controlled trial. Jesam C, Salvatierra AM, Schwartz JL, Fuentes A, Croxatto HB. Contraception; 2014 Aug 28; 90(2):168-73. PubMed ID: 24909636 [Abstract] [Full Text] [Related]
36. Ameliorative effect of combined administration of inducible nitric oxide synthase inhibitor with cyclooxygenase-2 inhibitors in neuropathic pain in rats. Dudhgaonkar SP, Tandan SK, Kumar D, Naik AK, Raviprakash V. Eur J Pain; 2007 Jul 28; 11(5):528-34. PubMed ID: 16920373 [Abstract] [Full Text] [Related]
38. Comparison of inhibitory effects of meloxicam and diclofenac on human thromboxane biosynthesis after single doses and at steady state. Tegeder I, Lötsch J, Krebs S, Muth-Selbach U, Brune K, Geisslinger G. Clin Pharmacol Ther; 1999 May 28; 65(5):533-44. PubMed ID: 10340919 [Abstract] [Full Text] [Related]
39. [Percutaneous absorption of meloxicam patches in hairless mouse]. Gao QZ, Yang LY, Ding PT, He ZG. Yao Xue Xue Bao; 2007 Dec 28; 42(12):1320-2. PubMed ID: 18338648 [Abstract] [Full Text] [Related]
40. Aspirin but not meloxicam attenuates early atherosclerosis in apolipoprotein E knockout mice. Kraus S, Naumov I, Shapira S, Kazanov D, Aroch I, Afek A, Eisenberg O, George J, Arber N, Finkelstein A. Isr Med Assoc J; 2014 Apr 28; 16(4):233-8. PubMed ID: 24834760 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]